Stonvex
Stonvex
StonvexWhat you need to know right now
This is an algorithmic assessment of current technical conditions, not investment advice. Past performance does not guarantee future results.
Real-time TradingView chart with full indicator set.
Last 7 days, powered by Finnhub. Tap Analyze to classify direction.
Loading latest news…
Pick the depth your tier unlocks. Logged-in Pro/Premium users automatically get the deeper report.
Free preview · 3 reports / hour · No sign-up required
Factor grades, AI Copilot, personalized ranking, and deeper event analysis.
Upgrade to Pro →Next report date, year-over-year trend, and recent quarter history.
5-factor analysis: Valuation, Growth, Profitability, Momentum, Financial Health.
Factor scoring needs Finnhub-supplied fundamentals — Finnhub returned no fundamental metrics for this ticker. Common for ETFs, foreign filers without US listing depth, recent IPOs, and thinly-traded OTC names.
6-factor scoring with sector-relative rank. Updated daily.
Share this analysis with other traders
Disclaimer: The content on this page is for informational and educational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Past performance does not guarantee future results. Consult a licensed financial advisor before making any investment decisions.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Date | Open | Close | Δ | Vol |
|---|---|---|---|---|
| 05-13 | $7.91 | $8.10 | +2.40% | 5.9M |
| 05-14 | $8.15 | $7.89 | -3.19% | 5.3M |
| 05-15 | $7.82 | $7.65 | -2.17% | 4.1M |
| 05-18 | $7.64 | $7.80 | +2.09% | 3.6M |
| 05-19 | $7.87 | $7.73 | -1.78% | 3.4M |
LifeStance Health Group Inc is a mental healthcare company that operates as a provider of outpatient mental health services, spanning psychiatric evaluations and treatment, psychological and neuropsychological testing, and individual, family, and group therapy. It treats a broad range of mental health conditions, including anxiety, depression, bipolar disorder, eating disorders, psychotic disorders, and post-traumatic stress disorder, using evidence-based approaches to ensure effective treatment. The group has a single operating and reportable segment of mental health services.
Indicator values from Polygon. Educational only — single- indicator triggers in isolation are not a complete trading signal.
Aggregated from Polygon's per-article sentiment classifications. Educational — sentiment is descriptive, not predictive.
These are published opinions from external sell-side analysts — not Stonvex recommendations. Ratings may change without notice, may conflict with each other, and may be wrong. Not investment advice.
Consensus aggregated from publicly disclosed sell-side analyst ratings. Stonvex is not a registered investment advisor and does not endorse any of the ratings shown. Past analyst ratings do not predict future price movements.
Documents are served directly from sec.gov / the issuer's website — Stonvex does not proxy or store filings.
| Metric | Annual 2021 2021-12-31 | Q3 2021 2021-09-30 | Q2 2021 2021-06-30 | Annual 2020 2020-12-31 |
|---|---|---|---|---|
Revenue | $1.45M | $1.45M | $1.45M | $142.00K |
Operating Income | $-286.35M | $-172.59M | $-47.93M | $6.74M |
Net Income | $-307.20M | $-199.17M | $-78.72M | $-13.13M |
EPS (Diluted) | $-1.05 | $-0.73 | $-0.37 | $-0.04 |
Total Assets | $1.93B | $1.91B | $1.91B | $1.57B |
Total Liabilities | $382.08M | $369.89M | $369.80M | $536.89M |
Cash & Equivalents | $148.03M | $212.12M | $276.19M | $18.83M |
Free Cash Flow OCF − CapEx | $-85.07M | $-77.03M | $-38.81M | $-47.23M |
Shares Outstanding | 374.25M | 374.15M | 374.15M | 0 |
Latest Form 13F-HR disclosures from the curated Super Investors list. Click through to see each manager's full long book.